(CIDRAP News) – Commercially available rapid influenza diagnostic tests (RIDTs) detected common virus strains at high concentrations fairly well but performed variably at lower concentrations, an evaluation of all 11 Food and Drug Administration–approved RIDTs showed.
Editor’s Note: This article covers research conducted by CIDRAP scientists. Please note that CIDRAP News operates independently in relation to CIDRAP's research and policy programs.
The world needs much better influenza vaccines, but the quest for them faces a formidable barrier: overconfidence about the effectiveness of existing influenza vaccines.